Skip to main content
. 2021 Nov 2;50(2):507–511. doi: 10.1007/s15010-021-01725-3

Table 1.

Cohort characteristics

Variable N (%)
(n = 70)a
Demographics
 Male:Female 46:24
 Age, median (IQR) years 37 (32–41)
 Temporary accommodation or no fixed abode 20 (28.6)
Substance use
 Alcohol excess 10 (14.3)
 Heroin only 29 (41.4)
  + Cocaine 26 (37.1)
  + Benzodiazepines 26 (37.1)
  + Cannabis 9 (12.9)
  + New psychoactive substance 5 (7.1)
  + Others 6 (8.6)
Blood borne viruses
 HIV positive 0
 Active HBV 2 (2.9)
 Active HCV 22 (31.4)
 Prior cleared HCV 15 (21.4)
Presentation
 Symptom duration prior to admission, median (IQR) days 4.5 (3–7)
 Vital signs, median (IQR)
  Pulse, beats/min 102 (85–118)
  Systolic BP, mmHg 113 (90–123)
  SpO2, % 97 (95–99)
  Temperature, °C 38.4 (37.5–39)
  Respiratory rate, breaths/min 17 (16–19)

Antimicrobial durations,

median (IQR) daysb

 Intravenous 18 (7–29)
 Oral follow-on (n = 54) 14 (14–27)
 Combined 29 (28–43)
Surgical intervention
 Abscess drainage 13 (18.6)
 Pseudoaneurysm ligation 4 (5.7)
Complications
 Bacteraemia 39/66 (59.1)c
 Septic pulmonary emboli 27 (38.6)
 Groin abscess 24 (34.3)
 Arterial involvement 8 (11.4)
 Pseudoaneurysm 6 (8.6)
 Splenic emboli 3 (4.3)
 Infective endocarditis 3 (4.3)
Outcomes
 Clinical cure 62 (88.6)
 Microbiological cure 38/39 (97.4)
 Substance-use related admission in year after discharge 32 (45.7)

Data shown as n (%) unless otherwise stated

aDenominator = 70 unless otherwise stated

bData available for n = 68

cBlood cultures obtained in n = 66

IQR interquartile range, HIV human immunodeficiency virus, HBV hepatitis B virus, HCV hepatitis C virus, BP blood pressure, SpO2 oxygen saturations